Cargando…
Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population‐based study
BACKGROUND: Stage IV gastric signet ring cell carcinoma (SRCC) is a type of malignant gastric cancer (GC) with poorer survival compared to metastatic non‐SRCC gastric cancer (NOS). However, chemotherapy alone was unable to maintain long‐term survival. This study aimed to evaluate survival benefit of...
Autores principales: | Shi, Tao, Song, Xueru, Liu, Qin, Yang, Yang, Yu, Lixia, Liu, Baorui, Wei, Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792481/ https://www.ncbi.nlm.nih.gov/pubmed/31448584 http://dx.doi.org/10.1002/cam4.2521 |
Ejemplares similares
-
Improving survival of stage II‐III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy
por: Li, Yang, et al.
Publicado: (2020) -
TAZ Is Highly Expressed in Gastric Signet Ring Cell Carcinoma
por: Yue, Guofeng, et al.
Publicado: (2014) -
Individualised adjuvant immunotherapy with neoantigen‐reactive T cells for gastric signet‐ring cell carcinoma
por: Ding, Naiqing, et al.
Publicado: (2023) -
CRS + HIPEC combined with IP + IV chemotherapy for gastric signet-ring cell carcinoma: Case report of long-term survival
por: Yan, Guo-Jun, et al.
Publicado: (2020) -
Survival benefits of gastrectomy in gastric cancer patients with stage IV: a population-based study
por: He, Xingkang, et al.
Publicado: (2017)